• Home
• About
• Login
• Register
• Search
• Current
• Archives
• Announcements
• Books For Review
• Manuscript Submission
• Editorial Review Board
• Permissions and Licensing
• Advertising Information
• Library Referral Form
• Reprints
• Register
• Subscription Information
• Seven Sins of Opioid Prescription
• Privacy
• Special Issue on Buprenophine
• User License Agreement
• BUPE2021

Open Access  Subscription or Fee Access

Table of Contents

Editorial

Physician identification of opioid diversion: A difficult diagnosis Gary M. Reisfield, MD, Paul A. Sloan, MD

PDF 5-6

Articles

Palliative care in the management of lung cancer: Analgesic utilization and barriers to optimal pain management Charles B. Simone II, MD, Neha Vapiwala, MD, Margaret K. Hampshire, BSN, James M. Metz, MD

PDF 9-16

Report of an HIV clinic-based pain management program and utilization of health status and health service by HIV patients Ahashta Johnson, MD, Kathleen DiGangi Condon, ANP-BC, MS, MA, Ann Celeste Mapas-Dimaya, MD, Judith Schrager, RN, PMHNP-BC, Robert Grossberg, MD, Rosalyn Gonzalez, BA, CASAC, Sean O’Mahony, MB, BCh, BAO, MS

PDF 17-27

Buprenorphine therapy for opioid addiction in rural Washington: The experience of the early adopters Tyler L. Quest, BS, Joseph O. Merrill, MD, John Roll, PhD, Andrew J. Saxon, MD, Roger A. Rosenblatt, MD, MPH

PDF 29-38

PCA-derived factors that may be predictive of postoperative pain in pediatric patients: A possible role for the PCA ratio Conor Mc Donnell, MD, MB, Carolyne Pehora, MN, Mark W. Crawford, MBBS

PDF 39-44

Urinalysis-based comparative evaluation of pattern of use of dextropropoxyphene and buprenorphine among opioid-dependent subjects Yatan Pal Singh Balhara, MD, DNB (Psychiatry), MNAMS, Raka Jain, PhD, CChem, FRSC

PDF 45-49

Should morphine dosing be weight based for analgesia in the emergency department? Asad E. Patanwala, PharmD, Christopher J. Edwards, PharmD, Lori Stolz, MD, Richard Amini, MD, Amol Desai, MD, Uwe Stolz, PhD, MPH

PDF 51-55

Case Studies

Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose Michael A. Yokell, ScB, Nickolas D. Zaller, PhD, Traci C. Green, PhD, MSc, Michelle McKenzie, MPH, Josiah D. Rich, MD, MPH

PDF 63-66

Opioid withdrawal-induced hypomania: A case series Navid Khalili, MD, Shahrokh Sardarpour Gudarzi, MD

PDF 67-72

Ideas and Innovations

The Opioid Manager: A point-of-care tool to facilitate the use of the Canadian Opioid Guideline Andrea D. Furlan, MD, PhD, Rhoda Reardon, Dip(P&OT), Lena Salach, MA

PDF 57-61

Full Issue

January February 2012 Full Issue

PDF 1-72